Companies Dominating the Palm Vein Scanner Landscape
- NEC Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- M2SYS Technology
- BioSec Group Ltd.
- Eportation Inc.
- Mantra Softtech Pvt Ltd.
- BioEnable Technologies Pvt Ltd.
- Imprivata, Inc.
- Recogtech B.V.
- Neurotechnology
- Mofiria Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of palm vein scanner is evaluated at USD 1.03 billion.
The palm vein scanner market size was valued at USD 747.86 million in 2024 and is set to exceed USD 10.13 billion by 2037, registering over 22.2% CAGR during the forecast period i.e., between 2025-2037. Increasing demand for advanced biometrics, and growing cases of fraudulence will boost the market growth.
North America industry is predicted to dominate majority revenue share of 36% by 2037, attributed to rising government initiative to secure hospital data and prevent network breaches.
The major players in the market are NEC Corporation, M2SYS Technology, BioSec Group Ltd., Eportation Inc., Mantra Softtech Pvt Ltd., BioEnable Technologies Pvt Ltd., Imprivata, Inc., Recogtech B.V., Neurotechnology, Mofiria Corporation
